Literature DB >> 360512

Stimuli for the production and control of IgE in rats.

E E Jarrett.   

Abstract

In Hooded Lister rats IgE responses may be induced by administration of antigen together with one of a number of adjuvants. The primary IgE response may subsequently be enhanced either specifically by a further exposure to antigen (booster response) or non-specifically by infection with helminth parasites (potentiated response). In the latter case the enhanced response is associated with a great increase in total serum IgE. The primary response itself is not significantly influenced by variations in the general theme of conventional immunization, including dose or route of administration of antigen, or the nature of the adjuvant employed. The booster response however is inhibited, a) in rats primed with a 'large' (e.g. greater than 100 microgram EA) dose of antigen and B. pertussis, and b) rats primed with any dose of antigen given in Al(OH)3 or CFA, and c) following repeated booster doses of soluble (i.e. unadjuvanted antigen even at a dosage of a few picogrammes. It is thought that each of the stimuli generate antigen specific suppressor T cells. Live worm parasites selectively, but non-specifically, stimulate heterologous antigen primed IgE responses. The evidence suggests that it may be this non-specific IgE stimulating effect rather than the parasite specific IgE response per se which leads to the great elevation of total serum IgE. Other immunoglobulin classes are not elevated in the same way. The potentiated IgE response is not susceptible to the suppressive influence generated by previous administration of large or repeated doses of the heterologous antigen. On the other hand, a parasite specific regulatory mechanism acts to prevent repotentiation of the heterologous (but not the parasite specific or total IgE) responses following reinfection. These results are discussed in relation to the work of others in rats and other species.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 360512     DOI: 10.1111/j.1600-065x.1978.tb01460.x

Source DB:  PubMed          Journal:  Immunol Rev        ISSN: 0105-2896            Impact factor:   12.988


  22 in total

Review 1.  Can persistent IgE responses be suppressed?

Authors:  D M Kemeny; D Diaz-Sanchez
Journal:  Clin Exp Immunol       Date:  1990-12       Impact factor: 4.330

Review 2.  The role of interleukin-4 in IgE and IgG subclass formation.

Authors:  H L Spiegelberg
Journal:  Springer Semin Immunopathol       Date:  1990

3.  Human IgE biosynthesis by tonsils.

Authors:  K Ohta; A Ishii; T Horiuchi; T Miyamoto; C H Kirkpatrick
Journal:  Clin Rev Allergy       Date:  1989

4.  IgE response in Strongyloides ratti-infected rats with special reference to the life cycle of the parasite.

Authors:  M Korenaga; Y Nawa; I Tada
Journal:  Z Parasitenkd       Date:  1986

5.  Inhibition of antigen-induced histamine release from rat mast cells by a cyclic GMP-phosphodiesterase inhibitor and sodium nitrite.

Authors:  N Frossard; G Pauli; Y Landry
Journal:  Agents Actions       Date:  1981-12

6.  Polyclonal IgE increase after HgCl2 injections in BN and LEW rats: a genetic analysis.

Authors:  C Sapin; F Hirsch; J P Delaporte; H Bazin; P Druet
Journal:  Immunogenetics       Date:  1984       Impact factor: 2.846

Review 7.  Recent studies on the regulation of IgE antibody synthesis in experimental animals and man.

Authors:  D H Katz
Journal:  Immunology       Date:  1980-09       Impact factor: 7.397

8.  Elimination of IgE regulatory rat CD8+ T cells in vivo differentially modulates interleukin-4 and interferon-gamma but not interleukin-2 production by splenic T cells.

Authors:  D Diaz-Sanchez; A Noble; D Z Staynov; T H Lee; D M Kemeny
Journal:  Immunology       Date:  1993-04       Impact factor: 7.397

9.  Effects of cyclic AMP- and cyclic GMP- phosphodiesterase inhibitors on immunological release of histamine and on lung contraction.

Authors:  N Frossard; Y Landry; G Pauli; M Ruckstuhl
Journal:  Br J Pharmacol       Date:  1981-08       Impact factor: 8.739

10.  IgE class-restricted tolerance induced by neonatal administration of soluble or cell-bound IgE. Cellular mechanisms.

Authors:  S S Chen; F T Liu; D H Katz
Journal:  J Exp Med       Date:  1984-10-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.